Latest profit margin for Orient EuroPharma , Ltd.: -11.58% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), 4120.TWO shows a profit margin of -11.58%. That compares with -7.2% in the prior-year period — down 60.7% year over year. That is below the sector sector average of 13.2%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 4120.TWO's profit margin is now -11.58% (was -7.2%) — a 60.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orient EuroPharma , Ltd. is outperforming or lagging.
The its sector sector average profit margin is about 13.2%. Orient EuroPharma , Ltd. is at -11.58%, which is lower that average. That is roughly 187.7% below the sector mean. Use the comparison chart on this page to see how 4120.TWO stacks up against individual peers as well.
That compares with -7.2% in the prior-year period — down 60.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Orient EuroPharma , Ltd. with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Orient EuroPharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -11.58%) with ownership activity and broader fundamentals.